OBSERVE Competitors

Stocks . Germany . 
Stock . OBSERVE MEDICAL ASA
OM5A Stock  EUR 0.03  0.0006  1.99%   
OBSERVE MEDICAL ASA competes with Axcelis Technologies, PKSHA TECHNOLOGY, Uber Technologies, SOFI TECHNOLOGIES, and COPLAND ROAD; as well as few others. The company operates under Healthcare sector and is part of Medical Devices industry. Analyzing OBSERVE MEDICAL competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of OBSERVE MEDICAL to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out OBSERVE MEDICAL Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of OBSERVE MEDICAL competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.000.034.43
Details
Intrinsic
Valuation
LowRealHigh
0.000.024.42
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as OBSERVE MEDICAL. Your research has to be compared to or analyzed against OBSERVE MEDICAL's peers to derive any actionable benefits. When done correctly, OBSERVE MEDICAL's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in OBSERVE MEDICAL ASA.

OBSERVE MEDICAL Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between OBSERVE MEDICAL and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of OBSERVE and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of OBSERVE MEDICAL ASA does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
6B0
+ 0.8
762
3GH
+ 0.62
TTG
3GH
+ 0.62
UT8
UT8
+ 0.58
XXA1
UT8
+ 0.56
TTG
3GH
+ 0.45
XXA1
  
High negative correlations   
6B0
- 0.94
XXA1
762
- 0.69
XXA1
6B0
- 0.56
UT8
3GH
- 0.56
762
3GH
- 0.51
6B0
UT8
- 0.43
762

Risk-Adjusted Indicators

There is a big difference between OBSERVE Stock performing well and OBSERVE MEDICAL Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze OBSERVE MEDICAL's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

OBSERVE MEDICAL Competitive Analysis

The better you understand OBSERVE MEDICAL competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, OBSERVE MEDICAL's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across OBSERVE MEDICAL's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
OM5A XXA1 TTG 762 UT8 6B0 A2P 3GH
 1.99 
 0.03 
OBSERVE
 3.06 
 67.28 
Axcelis
 2.05 
 0.07 
THORNEY
 0.87 
 22.80 
PKSHA
 0.80 
 59.18 
Uber
 0.68 
 14.71 
SOFI
 1.95 
 44.35 
COPLAND
 0.94 
 31.70 
Kaufman
Market Volatility
(90 Days Market Risk)
Out of control
Very steady
Out of control
Not too volatile
Very steady
Not too volatile
Very steady
Very steady
Market Performance
(90 Days Performance)
Weak
Very Weak
Weak
Insignificant
Very Weak
Strong
Very Weak
Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Quite High
Low
Quite High
Low
Below Average
Below Average
Low
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Under Valued
Over Valued
Under Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Sell
Strong Sell
Buy
Cautious Hold
Strong Buy
Strong Sell
Strong Sell
Current Ratio
3.00 X
N/A
14.38 X
17.44 X
N/A
N/A
N/A
1.33 X
Net Asset
N/A
1.01 B
N/A
N/A
32.11 B
N/A
N/A
1.47 B
Profit Margin
(2.44) %
N/A
N/A
0.07 %
N/A
(0.21) %
N/A
0.04 %
EBITDA
(43.34 M)
222.07 M
N/A
3.03 B
(7.91 B)
N/A
N/A
91.32 M
Operating Margin
(2.65) %
N/A
1.10 %
0.14 %
N/A
(0.21) %
N/A
0.07 %
Current Valuation
N/A
2.38 B
N/A
N/A
57.88 B
N/A
N/A
573.28 M
Price To Book
N/A
4.48 X
N/A
N/A
8.69 X
N/A
N/A
2.66 X
Beta
1.52
N/A
1.25
1.56
N/A
1.38
N/A
1.05
Number Of Employees
N/A
N/A
N/A
419
N/A
2.5 K
N/A
9
Shares Outstanding
53.49 M
N/A
257.37 M
30.65 M
N/A
927.94 M
N/A
21.12 M
Cash Flow From Operations
(21.64 M)
215.61 M
(7.93 M)
(179 M)
642 M
N/A
N/A
92.29 M
Annual Yield
N/A
N/A
N/A
N/A
N/A
N/A
N/A
0.07 %
Total Debt
35.22 M
N/A
N/A
2.03 B
9.27 B
N/A
N/A
149.39 M
Return On Equity
-0.57
N/A
-0.27
0.0303
-3.71
-0.0627
N/A
0.26
Z Score
N/A
N/A
N/A
N/A
3.6
N/A
N/A
2.4
Return On Asset
-0.21
N/A
-0.24
0.0275
N/A
-0.0227
N/A
0.0412
Book Value Per Share
3.01 X
N/A
0.36 X
942.98 X
N/A
5.62 X
N/A
11.31 X
Total Asset
N/A
1.01 B
N/A
N/A
32.11 B
N/A
N/A
1.47 B
Debt To Equity
1.73 %
N/A
N/A
0.07 %
N/A
N/A
N/A
60.60 %
Last Dividend Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
2.4
Shares Owned By Institutions
8.08 %
N/A
22.28 %
11.08 %
N/A
35.08 %
N/A
26.69 %
Market Capitalization
10.07 M
1.95 B
27.54 M
376.96 M
62.15 B
5.79 B
N/A
599.83 M
Price To Earning
N/A
N/A
4.62 X
31.97 X
N/A
N/A
N/A
10.75 X
Price To Sales
N/A
3.29 X
N/A
N/A
1.84 X
N/A
N/A
0.42 X
Net Income
(36.87 M)
183.08 M
24.4 M
1.74 B
(9.14 B)
N/A
N/A
43.87 M
Earnings Per Share
(0.06) X
N/A
0.06 X
0.19 X
N/A
0.61 X
N/A
2.13 X
Shares Owned By Insiders
55.17 %
N/A
28.10 %
48.88 %
N/A
6.41 %
N/A
46.49 %
Revenue
18.98 M
920 M
(59.9 M)
11.51 B
31.88 B
1.52 B
N/A
1.28 B
Cash And Equivalents
18.95 M
N/A
123.58 M
21.7 B
N/A
N/A
N/A
204.43 M
Cash Per Share
0.97 X
N/A
0.34 X
711.23 X
N/A
N/A
N/A
9.53 X
Gross Profit
9.52 M
N/A
(59.9 M)
5.73 B
N/A
1.21 B
N/A
228.17 M
Day Typical Price
0.0301
66.84
0.0715
22.8
59.06
14.88
43.38
31.7
Accumulation Distribution
0.0513
0.0196
N/A
N/A
0.0151
0.0329
0.0654
N/A
Market Facilitation Index
0.0016
1.32
N/A
N/A
0.9
0.5
2.9
N/A
Daily Balance Of Power
(0.38)
1.515152
(9,223,372,036,855)
(9,223,372,036,855)
0.5222
(0.20)
0.2931
(9,223,372,036,855)
Period Momentum Indicator
(0.0006)
2.0
(0)
(0.20)
0.47
(0.10)
0.85
(0.30)
Rate Of Daily Change
0.98
1.03
0.98
0.99
1.01
0.99
1.02
0.99
Day Median Price
0.0304
66.62
0.0715
22.8
59.0
14.96
42.9
31.7
Price Action Indicator
(0)
1.66
(0.0008)
(0.10)
0.41
(0.30)
1.88
(0.15)
Coefficient Of Variation
1267.68
(617.70)
4164.62
939.55
(1,865)
311.03
1633.03
4482.55
Mean Deviation
3.57
2.12
3.06
2.52
1.71
2.51
1.85
1.2
Jensen Alpha
0.3899
(0.49)
0.0852
0.3267
(0.18)
1.12
0.1399
0.0357
Total Risk Alpha
0.1728
(0.57)
(0.1)
0.2065
(0.27)
1.0
0.0365
(0.05)
Sortino Ratio
0.0781
N/A
0.013
0.1118
N/A
0.4718
0.0455
(0)
Downside Variance
21.53
N/A
22.02
8.26
N/A
5.67
6.43
2.46
Standard Deviation
5.16
2.74
4.4
3.44
2.66
3.63
2.61
1.73
Kurtosis
5.08
0.2187
1.11
1.67
5.98
5.19
1.26
7.74
Potential Upside
7.28
3.93
8.39
6.56
3.2
7.07
5.38
2.28
Treynor Ratio
1.97
(0.43)
0.3208
0.4231
(0.17)
1.02
0.5106
(0.14)
Maximum Drawdown
36.4
12.14
24.6
18.84
20.49
24.3
12.26
12.0
Variance
26.61
7.5
19.34
11.82
7.1
13.19
6.83
3.0
Market Risk Adjusted Performance
1.98
(0.42)
0.3308
0.4331
(0.16)
1.03
0.5206
(0.13)
Risk Adjusted Performance
0.0715
(0.12)
0.0274
0.0928
(0.04)
0.2649
0.0559
0.0232
Skewness
1.25
(0.02)
0.1742
0.9181
(0.64)
1.42
0.0956
1.49
Semi Deviation
3.89
N/A
3.82
2.32
N/A
1.78
2.25
1.5
Information Ratio
0.0702
(0.18)
0.0138
0.0934
(0.07)
0.3092
0.0441
(0)
Value At Risk
(5.77)
(5.61)
(7.74)
(4.17)
(4.53)
(3.12)
(4.94)
(2.32)
Expected Short fall
(4.47)
N/A
(3.99)
(3.69)
N/A
(3.30)
(2.34)
(1.24)
Downside Deviation
4.64
N/A
4.69
2.87
N/A
2.38
2.54
1.57
Semi Variance
15.13
N/A
14.57
5.41
N/A
3.16
5.05
2.26

OBSERVE MEDICAL Competition Performance Charts

Five steps to successful analysis of OBSERVE MEDICAL Competition

OBSERVE MEDICAL's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by OBSERVE MEDICAL ASA in relation to its competition. OBSERVE MEDICAL's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of OBSERVE MEDICAL in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact OBSERVE MEDICAL's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to OBSERVE MEDICAL ASA, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your OBSERVE MEDICAL position

In addition to having OBSERVE MEDICAL in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Aggressive Defence Thematic Idea Now

Aggressive Defence
Aggressive Defence Theme
Macroaxis small cap, aggressive-outlook picks designed for investors that are willing to accept higher levels of risk to hedge exposure to above-average market volatility. The Aggressive Defence theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Aggressive Defence Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in OBSERVE Stock

OBSERVE MEDICAL financial ratios help investors to determine whether OBSERVE Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in OBSERVE with respect to the benefits of owning OBSERVE MEDICAL security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY